T. Rowe Price Associates’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $523M | Sell |
|
|||||
|
2025
Q1 | $829M | Buy |
|
|||||
|
2024
Q4 | $393M | Sell |
|
|||||
|
2024
Q3 | $571M | Sell |
|
|||||
|
2024
Q2 | $769M | Sell |
|
|||||
|
2024
Q1 | $1.03B | Sell |
|
|||||
|
2023
Q4 | $897M | Buy |
|
|||||
|
2023
Q3 | $769M | Sell |
|
|||||
|
2023
Q2 | $1.74B | Sell |
|
|||||
|
2023
Q1 | $2.1B | Buy |
|
|||||
|
2022
Q4 | $1.69B | Buy |
|
|||||
|
2022
Q3 | $975M | Buy |
|
|||||
|
2022
Q2 | $832M | Sell |
|
|||||
|
2022
Q1 | $3.78B | Sell |
|
|||||
|
2021
Q4 | $5.43B | Sell |
|
|||||
|
2021
Q3 | $5.19B | Sell |
|
|||||
|
2021
Q2 | $4.54B | Sell |
|
|||||
|
2021
Q1 | $4.42B | Sell |
|
|||||
|
2020
Q4 | $4.14B | Buy |
|
|||||
|
2020
Q3 | $2.86B | Buy |
|
|||||
|
2020
Q2 | $2.18B | Sell |
|
|||||
|
2020
Q1 | $2.04B | Buy |
|
|||||
|
2019
Q4 | $2.97B | Buy |
|
|||||
|
2019
Q3 | $2.11B | Buy |
|
|||||
|
2019
Q2 | $2.15B | Buy |
|
|||||
|
2019
Q1 | $1.89B | Buy |
|
|||||
|
2018
Q4 | $1.61B | Buy |
|
|||||
|
2018
Q3 | $1.5B | Buy |
|
|||||
|
2018
Q2 | $964M | Buy |
|
|||||
|
2018
Q1 | $733M | Buy |
|
|||||
|
2017
Q4 | $458M | Sell |
|
|||||
|
2017
Q3 | $1.42B | Sell |
|
|||||
|
2017
Q2 | $1.59B | Buy |
|
|||||
|
2017
Q1 | $1.24B | Buy |
|
|||||
|
2016
Q4 | $613M | Sell |
|
|||||
|
2016
Q3 | $835M | Sell |
|
|||||
|
2016
Q2 | $939M | Sell |
|
|||||
|
2016
Q1 | $1.04B | Sell |
|
|||||
|
2015
Q4 | $961M | Buy |
|
|||||
|
2015
Q3 | $952M | Buy |
|
|||||
|
2015
Q2 | $1.08B | Buy |
|
|||||
|
2015
Q1 | $821M | Buy |
|
|||||
|
2014
Q4 | $781M | Buy |
|
|||||
|
2014
Q3 | $581M | Buy |
|
|||||
|
2014
Q2 | $311M | Sell |
|
|||||
|
2014
Q1 | $332M | Sell |
|
|||||
|
2013
Q4 | $323M | Sell |
|
|||||
|
2013
Q3 | $302M | Sell |
|
|||||
|
2013
Q2 | $266M | Buy |
|